{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:53:10Z","timestamp":1792979590175,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T00:00:00Z","timestamp":1185408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2007,9,21]]},"DOI":"10.1007\/s10928-007-9066-0","type":"journal-article","created":{"date-parts":[[2007,7,25]],"date-time":"2007-07-25T17:38:29Z","timestamp":1185385109000},"page":"711-726","source":"Crossref","is-referenced-by-count":463,"title":["Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies"],"prefix":"10.1007","volume":"34","author":[{"given":"Radojka M.","family":"Savic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00ebl M.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats O.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,26]]},"reference":[{"key":"9066_CR1","volume-title":"Clinical pharmacokinetics, concepts and applications","author":"M Rowland","year":"1994","unstructured":"Rowland M and Tozer TN (1994). Clinical pharmacokinetics, concepts and applications. Williams and Wilkins, Baltimore"},{"issue":"7","key":"9066_CR2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1023\/A:1018970924508","volume":"10","author":"NG Nerella","year":"1993","unstructured":"Nerella NG, Block LH and Noonan PK (1993). The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model. Pharm Res 10(7): 1031\u20131036","journal-title":"Pharm Res"},{"issue":"Suppl 1","key":"9066_CR3","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0169-409X(01)00179-X","volume":"50","author":"B Agoram","year":"2001","unstructured":"Agoram B, Woltosz WS and Bolger MB (2001). Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev 50(Suppl 1): S41\u2013S67","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"9066_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","volume":"186","author":"LX Yu","year":"1999","unstructured":"Yu LX and Amidon GL (1999). A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm 186(2): 119\u2013125","journal-title":"Int J Pharm"},{"issue":"2","key":"9066_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1020561807903","volume":"26","author":"MO Karlsson","year":"1998","unstructured":"Karlsson MO, Jonsson EN, Wiltse CG and Wade JR (1998). Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients. J Pharmacokinet Biopharm 26(2): 207\u2013246","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"9066_CR6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1997.00571.x","volume":"43","author":"T Rydberg","year":"1997","unstructured":"Rydberg T, Jonsson A, Karlsson MO and Melander A (1997). Concentration\u2013effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol 43(4): 373\u2013381","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"9066_CR7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2710.1995.tb00664.x","volume":"20","author":"T Rydberg","year":"1995","unstructured":"Rydberg T, Jonsson A and Melander A (1995). Comparison of the kinetics of glyburide and its active metabolites in humans. J Clin Pharm Ther 20(5): 283\u2013295","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"9066_CR8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diacare.17.9.1026","volume":"17","author":"T Rydberg","year":"1994","unstructured":"Rydberg T, Jonsson A, Roder M and Melander A (1994). Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans. Diabetes Care 17(9): 1026\u20131030","journal-title":"Diabetes Care"},{"key":"9066_CR9","volume-title":"NONMEM users guide: NONMEM project group","author":"LB Sheiner","year":"1992","unstructured":"Sheiner LB and Beal SL (1992). NONMEM users guide: NONMEM project group. University of California, San Francisco"},{"issue":"10","key":"9066_CR10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/0091270006291838","volume":"46","author":"O Osterberg","year":"2006","unstructured":"Osterberg O, Savic RM, Karlsson MO, Simonsson US, Norgaard JP and Walle JV (2006). Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. J Clin Pharmacol 46(10): 1204\u20131211","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"9066_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN and Karlsson MO (1999). Xpose\u2014an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58(1): 51\u201364","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"9066_CR12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P and Jonsson N (2005). PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed 79(3): 241\u2013257","journal-title":"Comput Methods Programs Biomed"},{"issue":"5","key":"9066_CR13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01059660","volume":"14","author":"LB Sheiner","year":"1986","unstructured":"Sheiner LB (1986). Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals. J Pharmacokinet Biopharm 14(5): 539\u2013555","journal-title":"J Pharmacokinet Biopharm"},{"issue":"2","key":"9066_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01059771","volume":"21","author":"JR Wade","year":"1993","unstructured":"Wade JR, Kelman AW, Howie CA and Whiting B (1993). Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis. J Pharmacokinet Biopharm 21(2): 209\u2013222","journal-title":"J Pharmacokinet Biopharm"},{"issue":"1","key":"9066_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00007691-200402000-00006","volume":"26","author":"A Rousseau","year":"2004","unstructured":"Rousseau A, Leger F, Le Meur Y, Saint-Marcoux F, Paintaud G and Buchler M (2004). Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator. Ther Drug Monit 26(1): 23\u201330","journal-title":"Ther Drug Monit"},{"issue":"6","key":"9066_CR16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1021\/js970414z","volume":"87","author":"YN Sun","year":"1998","unstructured":"Sun YN and Jusko WJ (1998). Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. J Pharm Sci 87(6): 732\u2013737","journal-title":"J Pharm Sci"},{"issue":"2","key":"9066_CR17","first-page":"734","volume":"295","author":"LE Friberg","year":"2000","unstructured":"Friberg LE, Freijs A, Sandstrom M and Karlsson MO (2000). Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats. J Pharmacol Exp Ther 295(2): 734\u201340","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-007-9066-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-007-9066-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-007-9066-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T08:56:40Z","timestamp":1559465800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-007-9066-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,26]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9,21]]}},"alternative-id":["9066"],"URL":"https:\/\/doi.org\/10.1007\/s10928-007-9066-0","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,26]]}}}